Neurochemical Research

, 33:1582 | Cite as

The PKC and ERK/MAPK Pathways Regulate Glucocorticoid Action on TRH Transcription

  • Antonieta Cote-Vélez
  • Leonor Pérez-Martínez
  • Jean-Louis Charli
  • Patricia Joseph-Bravo
Original Paper


Biosynthesis of TRH, a neuropeptide involved in energy homeostasis, is modulated by glucocorticoids. TRH mRNA and peptide levels are increased upon incubation of hypothalamic cells with dexamethasone or with cAMP analogs but when combined, a mutual antagonism is observed. These effects are observed at the transcriptional level and on binding of glucocorticoid receptor (GR) or pCREB to the composite GRE (cGRE) and CRE-2 sites of TRH promoter. The present work studied the involvement of PKC and MAPK pathways on the effect of dexamethasone and on its interaction with cAMP signaling in hypothalamic cell cultures. PKC or MEK inhibition abolished dexamethasone-stimulatory effect on TRH mRNA levels, as well as its interference with the stimulatory effect of 8Br-cAMP. Binding of nuclear extracts from hypothalamic or neuroblastoma cells stimulated with dexamethasone or 8Br-cAMP to oligonucleotides containing the CRE or cGRE sites of TRH gene promoter was decreased if cells were preincubated with PKC or MEK inhibitors. Mutations on the AP-1 or the GRE half sites of cGRE showed that GR binds as an heterodimer on cGRE, and PKC or MEK inhibitors diminish binding at the AP-1 site. PKC and ERK signaling thus modulate GR activity and its interaction with CREB or AP-1 at the TRH gene promoter.





We thank the technical support of F. Romero, M Villa, E. Martel, and E. Bustos, as well as S. González for animal care, and S. Ainsworth for bibliographic assistance. This work was supported by grants from CONACYT 43503 and DGAPA-UNAM 215507.


  1. 1.
    Gary KA, Sevarino KA, Yarbrough GC, Prange AJ, Winokur A (2003) The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics. J Pharmacol Exp Ther 305:410–416PubMedCrossRefGoogle Scholar
  2. 2.
    Perello M, Nillni EA (2007) The biosynthesis and processing of neuropeptides: lessons from prothyrotropin releasing hormone (proTRH). Front Biosci 12:3554–3565PubMedCrossRefGoogle Scholar
  3. 3.
    Joseph-Bravo P (2004) Hypophysiotropic thyrotropin-releasing hormone neurons as transducers of energy homeostasis. Endocrinology 145:4813–4815PubMedCrossRefGoogle Scholar
  4. 4.
    Lechan RM, Fekete C (2006) The TRH neuron: a hypothalamic integrator of energy metabolism. Prog Brain Res 153:209–235PubMedCrossRefGoogle Scholar
  5. 5.
    Uribe RM, Redondo JL, Charli JL, Joseph-Bravo P (1993) Suckling and cold stress rapidly and nucleus of lactating rats exposed to suckling or cold stimulation. Brain Res 1132:120–128Google Scholar
  6. 6.
    Sánchez E, Uribe RM, Corkidi G, Zoeller RT, Cisneros M, Zacarias M, Morales-Chapa C, Charli JL, Joseph-Bravo P (2001) Differential responses of thyrotropin-releasing hormone (TRH) neurons to cold exposure or suckling indicate functional heterogeneity of the TRH system in the paraventricular nucleus of the rat hypothalamus. Neuroendocrinology 74:407–422PubMedCrossRefGoogle Scholar
  7. 7.
    Arancibia S, Rage F, Astier H, Tapia Arancibia L (1996) Neuroendocrine and autonomous mechanisms underlying thermoregulation in cold environment. Neuroendocrinology 64:257–267PubMedCrossRefGoogle Scholar
  8. 8.
    Uribe RM, Pérez-Martínez L, Covarrubias ML, Gómez O, Covarrubias L, Charli JL, Joseph-Bravo P (1995) Phorbol ester or cAMP enhance thyrotropin-releasing hormone mRNA in primary cultures of hypothalamic cells. Neurosci Lett 201:41–44PubMedCrossRefGoogle Scholar
  9. 9.
    Pérez-Martínez L, Carreón-Rodríguez A, González-Alzati ME, Morales C, Charli JL, Joseph-Bravo P (1998) Dexamethasone rapidly regulates TRH mRNA levels in hypothalamic cell cultures: interaction with the cAMP pathway. Neuroendocrinology 68:345–354PubMedCrossRefGoogle Scholar
  10. 10.
    Cote-Vélez A, Pérez-Martínez L, Diaz-Gallardo MY, Pérez-Monter C, Carreón-Rodríguez A, Charli JL, Joseph-Bravo P (2005) Dexamethasone represses cAMP rapid upregulation of TRH gene transcription: identification of a composite glucocorticoid response element and a cAMP response element in TRH promoter. J Mol Endocrinol 34:177–197PubMedCrossRefGoogle Scholar
  11. 11.
    Lee SL, Stewart K, Goodman RH (1988) Structure of the gene encoding rat thyrotropin releasing hormone. J Biol Chem 263:16604–16609PubMedGoogle Scholar
  12. 12.
    Harris M, Aschkenasi C, Elias CF, Chandrankunnel A, Nillni EA, Bjorbaek C, Elmquist JK, Flier JS, Hollenberg AN (2001) Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J Clin Invest 107:111–120PubMedCrossRefGoogle Scholar
  13. 13.
    Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR (1990) Transcription factor interactions selectors of positive or negative regulation from a single DNA element. Science 249:1266–1272PubMedCrossRefGoogle Scholar
  14. 14.
    Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J, Krin M (1990) Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205–1215PubMedCrossRefGoogle Scholar
  15. 15.
    Pearce D, Matsui W, Miner J, Yamamoto KR (1998) Glucocorticoid receptor transcriptional activity determined by spacing of receptor and nonreceptor DNA sites. J Biol Chem 273:30081–30085PubMedCrossRefGoogle Scholar
  16. 16.
    Spitaler M, Cantrell DA (2004) Protein kinase C and beyond. Nat Immunol 5:785–790PubMedCrossRefGoogle Scholar
  17. 17.
    Schonwasser DC, Marais RM, Marshall CJ, Parker PJ (1998) Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol 18:790–798PubMedGoogle Scholar
  18. 18.
    Ismaili N, Garabedian MJ (2004) Modulation of glucocorticoid receptor function via phosphorylation. Ann NY Acad Sci 1024:86–101PubMedCrossRefGoogle Scholar
  19. 19.
    Krstic MD, Rogatsky I, Yamamoto KR, Garabedian MJ (1997) Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol Cell Biol 17:3947–3954PubMedGoogle Scholar
  20. 20.
    Miller AL, Webb MS, Copik AJ, Wang YX, Johnson BH, Kumar R, Thompson EB (2005) p38 mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: Correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol 19:1569–1583PubMedCrossRefGoogle Scholar
  21. 21.
    Revest JM, Di Blasi F, Kitchener P, Rougé-Pont F, Desmendt A, Turiault M, Tronche F, Piazza PV (2005) The MAPK pathway and Egr-1 mediate stress-related behavioral effects of glucocorticoids. Nat Neurosci 8:664–672PubMedCrossRefGoogle Scholar
  22. 22.
    Kassel O, Herrlich P (2007) Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Mol Cell Endocrinol 275:13–29PubMedCrossRefGoogle Scholar
  23. 23.
    Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR (2002) Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 22:7802–7811PubMedCrossRefGoogle Scholar
  24. 24.
    Clark AR, Lasa M (2003) Crosstalk between glucocorticoids and mitogen-activated protein kinase signaling pathways. Curr Opin Pharmacol 3:404–411PubMedCrossRefGoogle Scholar
  25. 25.
    Dickinson RJ, Keyse SM (2006) Diverse physiological functions for dual-specificity MAP kinase phosphatases. J Cell Sci 119:4607–4615PubMedCrossRefGoogle Scholar
  26. 26.
    Grewal JS, Randall DY, Stork P (1999) Extracellular-signal-regulated kinase signaling in neurons. Curr Opin Neurobiol 9:544–553PubMedCrossRefGoogle Scholar
  27. 27.
    Joseph-Bravo P, Pérez-Martínez L, Lezama L, Morales-Chapa C, Charli JL (2002) An improved method for the expression of TRH in serum-supplemented primary cultures of fetal hypothalamic cells. Brain Res Protoc 9:93–104CrossRefGoogle Scholar
  28. 28.
    Paxinos G, Ashwell KWS, Tork I (1995) Atlas of the developing rat nervous system, Second edn. Academic Press, Sydney, p xiGoogle Scholar
  29. 29.
    Meszaros JG, Roberth R, Lio FM, Brunton L (2000) Protein kinase C contributes to desensitization of ANG II signaling in adult rat cardiac fibroblast. Am J Physiol Cell Physiol 279:C1978–C1985PubMedGoogle Scholar
  30. 30.
    Isonishi S, Ohkawa K, Tanaka T, Howell SB (2000) Depletion of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cells. Can Res Camp 82:34–38Google Scholar
  31. 31.
    Wang D, Yu X, Brecher P (1998) Nitric acid and N-acetylcysteine inhibit the activation of mitogen-activated protein kinases by angiotensin II in rat cardiac fibroblasts. J Biol Chem 273:33027–33034PubMedCrossRefGoogle Scholar
  32. 32.
    Watters J, Cambell J, Cunninham M, Krebs E, Dorsa D (1997) Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signaling cascade and c-fos immediate early gene transcription. Endocrinology 138:4030–4033PubMedCrossRefGoogle Scholar
  33. 33.
    Deak M, Clifton A, Lucocq J, Alessi D (1998) Mitogen- and stress-activated protein kinase-1(MSK1) is directly activated by MAPK and SAPK/p38 and may mediate activation of CREB. EMBO J 17:4426–4441PubMedCrossRefGoogle Scholar
  34. 34.
    O’Carrol AM, Lolait SJ, Howell GM (2006) Transcriptional regulation of the rat apelin receptor gene: promoter cloning and identification of and Sp1 site necessary for promoter activity. J Mol Endocrinol 36:221–235CrossRefGoogle Scholar
  35. 35.
    Olsson AK, Vadhammar K, Nanberg E (2000) Activation and protein kinase C-dependent nuclear accumulation of ERK in differentiating human neuroblastoma cells. Exp Cells Res 256:454–467CrossRefGoogle Scholar
  36. 36.
    de Gortari P, Uribe RM, Garcia-Vázquez A, Aguilar-Valles A, Martínez A, Valdes A, Charli JL, Fernandez-Guardiola A, Joseph-Bravo P (2006) Amygdala kindling differentially regulates the expression of the elements involved in TRH transmission. Neurochem Int 48:31–42PubMedCrossRefGoogle Scholar
  37. 37.
    Atkinson T, Smith M (1984) Solid-phase synthesis of oligodeoxyribo-nucleotides by the phosphite-triester method. In: Gait MJ (ed) Oligonucleotide synthesis a practical approach. Practical approach series. IRL Press, Oxford Washington DC, EEUUGoogle Scholar
  38. 38.
    Pedraza-Alva G, Zingg JM, Jos JP (1994) AP-1 binds to a putative cAMP response element of the MyoD1 promoter and negatively modulates MyoD1 expression in dividing myoblast. J Biol Chem 269:6978–6985PubMedGoogle Scholar
  39. 39.
    Persaud SJ, Jones PM, Howell SL (1993) Staurosporine inhibits protein kinases activated by Ca2+ and cyclic AMP in addition to inhibiting protein kinase C in rat islets of Langerhans. Mol Cell Endocrinol 94:55–60PubMedCrossRefGoogle Scholar
  40. 40.
    Dahlman-Wright K, Wright A, Gustafsson JA, Carlstedt-Duke J (1991) Interaction of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids. J Biol Chem 266:3107–3112PubMedGoogle Scholar
  41. 41.
    Pace TWW, Hu F, Miller AH (2006) Cytokine-effects of glucocorticoid receptor function: relevance of glucocorticoid resistence and the pathophysiology and treatment of major depression. Brain Behav Immun 21:9–19PubMedCrossRefGoogle Scholar
  42. 42.
    de Kloet ER, Joels M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6:463–475PubMedCrossRefGoogle Scholar
  43. 43.
    Chrousos GP, Kino T (2005) Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci STKE 304:1–6Google Scholar
  44. 44.
    Webster CJ, Cidlowski AJ (1999) Mechanisms of glucocorticoid-receptor-mediated repression of gene expression. Trends Endocrinol Metab 10:396–402PubMedCrossRefGoogle Scholar
  45. 45.
    Szatmary Z, Garabedian MJ, Vilcek J (2004) Inhibition of glucocorticoid receptor-mediated transcriptional activation by p38 mitogen-activated protein (MAP) kinase. J Biol Chem 279:43708–43715PubMedCrossRefGoogle Scholar
  46. 46.
    Miller AL, Garza AS, Johnson BH, Thompson EB (2007) Pathway interactions between MAPK, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells. Cancer Cell Int 7:3PubMedCrossRefGoogle Scholar
  47. 47.
    Basta-Kaim A, Budziszewaska B, Jawarska-Feil L, Leskiewicz M, Tetich M, Otczyk M, Kubera M, Lason W (2006) Effects of neurosteroids on glucocorticoid receptor-mediated gene transcription in LMCAT cells- a possible interaction with psychotropic drugs. Eur Neuropsychopharmacol 17:37–45PubMedCrossRefGoogle Scholar
  48. 48.
    David S, Kalb RG (2005) Serum/glucocorticoid-inducible kinase can phosphorylate the cyclic AMP response element binding protein, CREB. FEBS Lett 579:1534–1538PubMedCrossRefGoogle Scholar
  49. 49.
    Heck S, Kullmann M, Gast A, Ponta H, Rahmsdorf HJ, Herrlich P, Cato AC (1994) A distinct modulating domain in glucocorticoid receptor monomer in the repression of activity of the transcription factor AP-1. Embo J 13:4087–4095PubMedGoogle Scholar
  50. 50.
    Mizuno H, Nishida E (2001) The ERK MAP kinase pathway mediates induction of SGK (serum- and glucocorticoid-inducible kinase) by growth factors. Genes Cells 6:261–268PubMedCrossRefGoogle Scholar
  51. 51.
    Dallman MF, Warne JP, Foster MT, Pecoraro NC (2007) Glucocorticoids and insulin both modulate caloric intake through actions on the brain. J Physiol 583:431–436PubMedCrossRefGoogle Scholar
  52. 52.
    Chalmers CJ, Gilley R, March HN, Balmanno K, Cook SJ (2007) The duration of ERK 1/2 activity determines the activation of c-Fos and Fra-1 and the composition and quantitative transcriptional output of AP-1. Cell Signal 19:695–704PubMedCrossRefGoogle Scholar
  53. 53.
    Hu Y, Peng J, Feng D, Chu L, Li X, Jin Z, Lin Z, Zeng Q (2006) Role of extracellular signal-regulated kinase, p38 kinase, and activator protein-1 in transforming growth factor-β1-induced alpha smooth muscle actin expression in human fetal lung fibroblast in vitro. Lung 184:33–42PubMedCrossRefGoogle Scholar
  54. 54.
    Charli JL, Cruz C, Redondo JL, Guerra C, Joseph-Bravo P (1995) Homologous conditioned medium enhances expression of TRH in hypothalamic neurons in primary culture. Dev Brain Res 89:155–160CrossRefGoogle Scholar
  55. 55.
    Impey S, Goodman RH (2001) CREB signaling: time is everything. Sci STKE 82:PE1Google Scholar
  56. 56.
    Imai E, Miner JN, Mitchell JA, Yamamoto KR, Granner DK (1993) Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem 268:5353–5356PubMedGoogle Scholar
  57. 57.
    Doucas V, Shi Y, Miyamoto S, West A, Verma I, Evans RM (2000) Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor. PNAS 97:11893–11898PubMedCrossRefGoogle Scholar
  58. 58.
    Kumar R, Thompson EB (2005) Gene regulation by the glucocorticoid receptor: structure: function relationship. J Ster Biochem and Mol Biol 94:383–394CrossRefGoogle Scholar
  59. 59.
    Onda K, Nagashima M, Kawakubo Y, Inoue S, Hirano T, Oka K (2006) Mitogen-activated protein kinase kinase 1/extracellular signal-regulated kinase (MEK-1/ERK) inhibitors sensitize reduced glucocorticoid response mediated by TNF alpha in human epidermal keratinocytes (HaCaT). Biochem Biophys Res Comm 351:266–272PubMedCrossRefGoogle Scholar
  60. 60.
    Buse P, Maiyar AC, Failor KL, Tran S, Leong MLL, Firestone GL (2007) The stimulus-dependent co-localization of serum- and glucocorticoid-regulated protein kinase (Sgk) and Erk/MAPK in mammary tumor cells involves the mutual interaction with the importin-alpha nuclear import protein. Exp Cell Res 313:3261–3275PubMedCrossRefGoogle Scholar
  61. 61.
    Joseph-Bravo P, Cote-Vélez A, Pérez-Martínez L (2006) Integration of neuroendocrine signals that regulate the activity of hypophysiotropic peptides. In: Joseph-Bravo P (ed) Molecular endocrinology. Research Signpost Ed, Kerala, India, pp 1–24Google Scholar
  62. 62.
    Guerra-Crespo M, Ubieta R, Joseph-Bravo P, Charli JL, Pérez-Martínez L (2001) BDNF increases the early expression of TRH rnRNA in fetal TrkB(+) hypothalamic neurons in primary culture. Eur J Neurosci 14:483–494PubMedCrossRefGoogle Scholar
  63. 63.
    Ubieta R, Uribe RM, González JA, García-Vázquez A, Pérez-Monter C, Pérez-Martínez L, Joseph-Bravo P, Charli JL (2007) BDNF up-regulates pre-pro-TRH mRNA expression in the fetal/neonatal paraventricular nucleus of the hipothalamus. Properties of the transduction pathway. Brain Res 1174:28–38PubMedCrossRefGoogle Scholar
  64. 64.
    Tapia-Arancibia L, Rage F, Givalois L, Arancibia S (2004) Physiology of BDNF: focus on hypothalamic function. Front Neuroendocrinol 25:77–107PubMedCrossRefGoogle Scholar
  65. 65.
    Gutiérrez-Mariscal M, de Gortari P, López-Rubalcava C, Martínez A, Joseph-Bravo P (2008) Analysis of the anxiolytic-like effect of TRH and the response of amigdalar TRHergic neurons in anxiety. Psychoneuroendocrinology 33:198–213PubMedCrossRefGoogle Scholar
  66. 66.
    Jaimes-Hoy L, Joseph-Bravo P, de Gortari P (2008) Differential response of TRHergic neurons of the hipothalamic paraventricular nucleus (PNV) in animals submitted to food-restriction or dehydration-induced anorexia and cold exposure. Horm Behav 53:366–377PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Antonieta Cote-Vélez
    • 1
  • Leonor Pérez-Martínez
    • 1
  • Jean-Louis Charli
    • 1
  • Patricia Joseph-Bravo
    • 1
  1. 1.Departamento de Genética y Fisiología Molecular, Instituto de BiotecnologíaUniversidad Nacional Autónoma de México (UNAM)CuernavacaMexico

Personalised recommendations